BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang ZY, Guo S, Zhao R, Ji ZP, Zhuang ZN. Clinical significance of SQSTM1/P62 and nuclear factor-κB expression in pancreatic carcinoma. World J Gastrointest Oncol 2020; 12(7): 719-731 [PMID: 32864040 DOI: 10.4251/wjgo.v12.i7.719]
URL: https://www.wjgnet.com/1948-5204/full/v12/i7/719.htm
Number Citing Articles
1
Xiaochuan Zhang, Mengge Dai, Shaotong Li, Meng Li, Bing Cheng, Ting Ma, Zheng Zhou. The emerging potential role of p62 in cancer treatment by regulating metabolismTrends in Endocrinology & Metabolism 2023; 34(8): 474 doi: 10.1016/j.tem.2023.05.004
2
Shimin Chen, Enfa Zhao. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2021; 45(5): 101587 doi: 10.1016/j.clinre.2020.101587
3
Huili Ren, Jianglin Zheng, Qi Cheng, Xiaoyan Yang, Qin Fu. Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular CarcinomaFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.900713
4
Jacob Cuyler, Pranav Murthy, Neal G. Spada, Terence F. McGuire, Michael T. Lotze, Xiang-Qun Xie. Sequestsome-1/p62-targeted small molecules for pancreatic cancer therapyDrug Discovery Today 2022; 27(1): 362 doi: 10.1016/j.drudis.2021.09.011
5
Christian Bailly. Anticancer Targets and Signaling Pathways Activated by Britannin and Related Pseudoguaianolide Sesquiterpene LactonesBiomedicines 2021; 9(10): 1325 doi: 10.3390/biomedicines9101325